Advertisement

Topics

Latest "COLORADO SERUM COMPANY" News Stories

18:33 EDT 20th September 2018 | BioPortfolio

Here are the most relevant search results for "COLORADO SERUM COMPANY" found in our extensive news archives from over 250 global news sources.

More Information about COLORADO SERUM COMPANY on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about COLORADO SERUM COMPANY for you to read. Along with our medical data and news we also list COLORADO SERUM COMPANY Clinical Trials, which are updated daily. BioPortfolio also has a large database of COLORADO SERUM COMPANY Companies for you to search.

Showing "COLORADO SERUM COMPANY" News Articles 1–25 of 17,000+

Thursday 20th September 2018

Merck Receives Positive CHMP Opinion for DELSTRIGO™ (doravirine/lamivudine/tenofovir disoproxil fumarate) and PIFELTRO™ (doravirine) in the European Union for the Treatment of HIV-1 Infection

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending granting of marketing authorization for two HIV-1 medicines: DELSTRIGO™, a once-daily fixed-dose combination tablet of dorav...


TransEnterix to Participate in Two Upcoming Healthcare Conferences

TransEnterix, Inc. (NYSE American:TRXC) announced today that TransEnterix will participate in two upcoming healthcare conferences: Todd M. Pope, President and Chief Executive Officer will present at the 2018 Cantor Global Healthcare Conference at The Intercontinental New York Barclay Hotel, New York. The presentation is scheduled to ...

Sarstedt Brothers Worlds Apart Together Folk Rock; Soft Rock 1973 UK Press

C $1.27 (0 Bids)End Date: Thursday Sep-27-2018 14:45:07 EDTBid now | Add to watch list Biotech365 : Sarstedt Brothers Worlds Apart Together Folk Rock; Soft Rock 1973 UK Press BioMarketplace You want to propose your products or a Biotech Company, … Continue reading → Cet article Sarstedt Brothers Worlds Apart Together Folk Rock; Soft Rock 1973 UK Press est apparu en premier sur ...


Puma Biotechnology to Present at Cantor Global Healthcare Conference

Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will provide an overview of the Company at 1:10 p.m. EDT on Monday, October 1, at the Cantor Global Healthcare Conference. The conference will be held at the InterContinental New York Barcl...

Stryker to host conference call on October 25, 2018

Kalamazoo, Michigan - September 20, 2018 - Stryker (NYSE:SYK) announced that it will host a conference call on Thursday, October 25, 2018 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended September 30, 2018 and provide an operational update. Final operating results for the quarter ended September 30, 2018 will be released at 4:05 p.m...

Kansas State University College of Engineering Names Netsmart Company of the Year

Kansas State University College of Engineering named Netsmart the 2018 Company of the Year at its 35th annual Career Fair Recognition. The award winner is chosen based on a company’s commi

Opsens Inc OPS Medical Equipment Deals and Alliances Profile [Report Updated: 16052018] Prices from USD $250

SummaryOpsens Inc Opsens is a diversified company. The company offers fiber optic sensing solutions for medical, oil and gas, and industrial applications. Its products include fiber optic pressure sensors, fiber optic strain sensors, fiber optic temperature sensors, fiber optic displacement sensors, fiber optic extensometer, signal conditioners, and OEM boards. Opsens provides fiber optic sensors ...

Invest in “Precision Health” to Better Care for High-Need, High-Cost Patients, AJMC® Researchers Say

Significant investments are needed in new comprehensive data networks that connect and integrateclinical factors, social determinants of health, and genomic information from multiple health systems inorder to improve care for high-need, high-cost patients, according to a commentary in The AmericanJournal of Managed Care®. AJMC® interviewed on...

VALNEVA Announces Extension of Drawdown Period for its Existing European Investment Bank Loan

Valneva Announces Extension of Drawdown Period for its Existing European Investment Bank Loan Saint Herblain (France), September 20, 2018 - Valneva SE ("Valneva" or "the Company"), a commercial stage biotech company focused on developing innovative lifesaving vaccines, announces today that it has agreed, with the European Investment Bank ("EIB"),  a one-year ...

Acadia Healthcare Company, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 23042018] Prices from USD $350

Acadia Healthcare Company, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Acadia Healthcare Company, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investments report includes business description, detailed reports on mergers and acquisitions MA, divestments, capital raisings, venture capital investments, ownership and partnership trans...

Covalon to Host Conference Call to Discuss Definitive Agreement to Acquire AquaGuard

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, has scheduled a conference call for Friday September 21st 2018 at 9:00am EST. The conference call is being held to discuss the announcement of Covalon’s definitive agreement to acquire AquaGuard, the Seattle, ...

KineMed Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12042018] Prices from USD $250

SummaryKineMed Inc KineMed is a biotechnology company that develops and commercializes proprietary biomarker platform technology. The company applies its proprietary biomarker platform technology to drug development, prescription, and nonprescription medical diagnostics and the pairing of drugs with diagnostic biomarker tests. It utilizes isotope labeling, mass spectrometry, and other techniques t...

GENEWIZ Inc Medical Equipment Deals and Alliances Profile [Report Updated: 11052018] Prices from USD $250

SummaryGENEWIZ Inc GENEWIZ is a contract research organization that offers genomics and technical support services. The organization's services comprise next generation sequencing, gene synthesis, sanger sequencing, molecular genetics, cloning and mutagenesis, plasmid DNA preparation, and GLPcomplaint services. It offers regulatory services such as bio therapeutics solutions, plasmid preparation, ...

UnitedHealthcare Invests $9 Million to Help Improve Quality of Care and Patient Services at 21 Golden Valley Health Center Locations in the Central Valley

Funding provides critical resources for new construction and renovation projects in Merced, Stanislaus and San Joaquin counties Investment part of UnitedHealthcare’s California Health Care Investment Program, a more than $400 million-dollar program to improve health care access for underserved communities statewide ...

Can Pancreastatin Levels Guide Therapy in NETS Patients Undergoing TACE?

For patients with NETs that have metastasized to the liver, high levels of serum pancreastatin are predictive of poor outcomes after treatment with TACE.

Coca-Cola Andina: Embotelladora Andina Announces Offer to Purchase for Cash Certain of its Debt Securities

SANTIAGO, CHILE / ACCESSWIRE / September 20, 2018 / Embotelladora Andina S.A. (the 'Company'), a Chilean publicly held corporation, announced today that it is offering to purchase for cash up to US...

Kalytera Therapeutics Provides Update for Lead Program in Prevention and Treatment of GVHD

Kalytera Therapeutics, Inc. (TSXV:KALY, OTCQB:KALTF) (the "Company" or "Kalytera") today provided an update on its lead product development program evaluating cannabidiol (“CBD”) for the prevention and treatment of acute graft versus host disease (“GVHD”). The post Kalytera Therapeutics Provides Update for Lead Program in Prevention and Treatment of GVHD appeared first on Investing News Ne...

Lennar Corporation's Third Quarter Earnings Conference Call To Be Broadcast Live On The Internet

MIAMI, Sept. 20, 2018 /PRNewswire/ -- Lennar Corporation (NYSE: LEN and LEN.B), one of the nation's largest homebuilders, announced today that the Company will release Read more...

National Suicide Prevention Organization Invests in Colorado-National Collaborative to Find ...

DENVER, Sept. 20, 2018 /PRNewswire/ -- Similar to other Rocky Mountain States, Colorado has higher suicide rates than the rest of the country. In 2017, Read more...

Canntab Sets New All-Time High Trading Prices and Volume

Canntab Therapeutics (CSE:PILL) ("Canntab" or the "Company"), a leader in the development of the cannabis in tablet or capsule form, is pleased to announce that the Company's common shares ("Common Shares") yesterday reached new all-time daily high and closing prices of $1.74 and $1.41, respectively, on the Canadian Securities Exchange (the "CSE"). The post Canntab Sets New All-Time High Trading P...

Former Lululemon Executive Joins True Leaf as Chief Financial Officer

DGAP-News: True Leaf Medicine International Ltd. / Key word(s): Market launch/Change of Personnel 20.09.2018 / 13:10 The issuer is solely responsible for the content of this announcement. Former Lululemon Executive Joins True Leaf as Chief Financial Officer Kerry Biggs brings NASDAQ-level finance and operations experience at pivotal time in company's growth VERNON, BC - September 20, ...

Medicrea Announces Eurospine 2018 Presence and Highlights a Recently Published Study Validating Its Predictive Modelling Approach for AIS Patients

The Medicrea Group (Euronext Growth Paris: FR0004178572 – ALMED, PEA-PME eligible, and OTCQX: MNRTY and MNRTF), pioneering the transformation of spinal surgeries through Artificial Intelligence, predictive modeling and patient specific implants with its UNiD™ ASI (Adaptive Spine Intelligence) technology, announced today that the Company is attending th...

Generex Subsidiary Hema Diagnostic Systems, LLC dba NuGenerex Diagnostics Announces Filing of a European CE Marking Application

Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) today announced that its subsidiary, Hema Diagnostic Systems, LLC dba NuGenerex Diagnostics (

New Report: Support Programs and Human Interaction Help Bring Employees Back to Work Faster After Disability Leave

The Standard’s study reveals comprehensive disability management programs can boost efforts around employee recruitment, retention and financial well-being Employees with health conditions are inevitable in the workplace. But in its Employee Disability Leave study, Standard Insurance Company (

Tenax Therapeutics to Present at Upcoming Investor Conferences

Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products for the critical care market, today announced that company management will present at the following upcoming investor conferences: Event: The MicroCap ConferencePresenter: Anthony DiTonno, CEODate: October 1, ...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks